Pacemaker News and Research RSS Feed - Pacemaker News and Research

Amgen announces phase 3 ivabradine data for treatment of chronic HF

Amgen announces phase 3 ivabradine data for treatment of chronic HF

Amgen (NASDAQ: AMGN) today announced data from the Phase 3 SHIFT (Systolic Heart failure treatment with the If inhibitor ivabradine Trial) study evaluating ivabradine in patients with chronic heart failure (HF) were presented at the 18th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) in Las Vegas. [More]
Permanent atrial fibrillation twins risk of stroke than paroxysmal AF

Permanent atrial fibrillation twins risk of stroke than paroxysmal AF

Permanent atrial fibrillation (AF) doubles the risk of stroke compared to paroxysmal AF, according to research in more than 6 000 patients presented at ESC Congress today by Dr Thomas Vanassche from Belgium. The findings suggest that a simple clinical assessment of the type of AF can help doctors to better estimate stroke risk. [More]
Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

The pacemaker or ICD unit, which is the implanted box or generator i.e. the electrical component of the device that's implanted in the chest, usually lasts between seven to 10 years before the generator’s battery is depleted. [More]
Researcher presents new batteryless cardiac pacemaker based on automatic wristwatch

Researcher presents new batteryless cardiac pacemaker based on automatic wristwatch

A new batteryless cardiac pacemaker based on an automatic wristwatch and powered by heart motion was presented at ESC Congress 2014 today by Adrian Zurbuchen from Switzerland. The prototype device does not require battery replacement. [More]
Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

Amgen today announced the U.S. Food and Drug Administration has granted priority review designation for ivabradine for the treatment of chronic heart failure (HF). [More]
Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Remote monitoring is the ability to follow patients who have implantable pacemakers or defibrillators from home. This technology was introduced in the U.S. in 2001 so it’s been available for close to 15 years. [More]
Biomedical engineering professor wins prestigious 2014 Early Career Achievement Award

Biomedical engineering professor wins prestigious 2014 Early Career Achievement Award

Qi Wang, assistant professor of biomedical engineering, recently won the prestigious 2014 Early Career Achievement Award from the IEEE Engineering in Medicine and Biology Society (EMBS). [More]
First peer-reviewed comprehensive expert guidance on the use of neurostimulation for pain

First peer-reviewed comprehensive expert guidance on the use of neurostimulation for pain

Reflecting groundbreaking international consensus regarding a group of rapidly evolving medical interventions for chronic pain, the International Neuromodulation Society announced it will soon publish the first peer-reviewed comprehensive expert guidance on the appropriate use of neurostimulation for pain. [More]
EnteroMedics reports net loss of $7.5 million for Q2 2014

EnteroMedics reports net loss of $7.5 million for Q2 2014

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced financial results for the three and six months ended June 30, 2014. [More]
Gene therapy offers potential alternative to pacemakers

Gene therapy offers potential alternative to pacemakers

Researchers have developed a gene transplant procedure that can transform ordinary heart muscle cells into “biological pacemaker” cells that maintain heart rhythm. [More]
Self-competence seems to decrease quality of life for children living with cardiac pacemaker

Self-competence seems to decrease quality of life for children living with cardiac pacemaker

For children and teens living with a cardiac pacemaker, a low sense of self-competence seems to contribute to decreased quality of life, reports a study in the July Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics. [More]
Cook Medical’s Evolution® RL Lead Extraction Products reintroduced to the US market

Cook Medical’s Evolution® RL Lead Extraction Products reintroduced to the US market

Effective immediately, Cook Medical customers in the United States will again have access to its Evolution® RL and Evolution® Shortie RL Controlled-Rotation Dilator Sheath Sets. Distribution of these products within the U.S. market was suspended for two months while Cook’s Lead Management clinical division worked with the U.S. Food and Drug Administration (FDA) to resolve agency questions about the marketing clearance of these products. The devices, which remained available in Europe and other markets, were not recalled by FDA. [More]
Researchers develop self-powered artificial cardiac pacemaker

Researchers develop self-powered artificial cardiac pacemaker

As the number of pacemakers implanted each year reaches into the millions worldwide, improving the lifespan of pacemaker batteries has been of great concern for developers and manufacturers. [More]
Huntington Memorial Hospital patient implanted with tiny, leadless cardiac pacemaker

Huntington Memorial Hospital patient implanted with tiny, leadless cardiac pacemaker

A Huntington Memorial Hospital patient has become the first patient in the San Gabriel Valley to be implanted with a tiny, leadless cardiac pacemaker. Developed for patients with bradycardia - a heart rate that is too slow - the Nanostim device is designed to be placed directly in a patient's heart without the visible lump, scar and insulated wires (called leads) required for conventional pacemakers. [More]
Cardiac Lead Extraction celebrates 25-Year anniversary at Cardiostim

Cardiac Lead Extraction celebrates 25-Year anniversary at Cardiostim

A quarter century ago, doctors treating patients with implanted cardiac pacemakers had a big problem. Their patients were outliving the complex electrical devices that gave them an acceptable quality of life. [More]
Stress may accelerate cognitive decline later in life

Stress may accelerate cognitive decline later in life

A new study published in the June 18 issue of The Journal of Neuroscience adds to a body of evidence suggesting stress may accelerate cognitive decline later in life. [More]
ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

ARIAD Pharmaceuticals, Inc. today announced, for the first time, data from its Phase 2 trial of Iclusig (ponatinib) in adult patients with refractory metastatic and/or unresectable gastrointestinal stromal tumors (GIST). [More]
BIOTRONIK ProMRI ICD trial expansion achieves FDA approval

BIOTRONIK ProMRI ICD trial expansion achieves FDA approval

BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration (FDA) has approved a significant expansion of its ongoing ProMRI® trial. [More]
NYU Langone Medical Center implants RNS device in brain for patients with epilepsy

NYU Langone Medical Center implants RNS device in brain for patients with epilepsy

NYU Langone Medical Center last month became the first hospital outside of a clinical trial site to implant a pacemaker-like device in the brain that may be a game-changer for patients with epilepsy. [More]
Implantable system improves sleep and heart function without mask

Implantable system improves sleep and heart function without mask

A novel device implanted under the skin like a pacemaker successfully treats central sleep apnoea (CSA) in heart failure patients, according to research presented today at the Heart Failure Congress 2014, held 17-20 May in Athens, Greece. [More]